Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized Spinal Anesthesia Dosing for Cesarean Section
NCT03497364Unknown
- Sponsor
- Shenzhen People's Hospital
- Start
- May 2018
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine and ropivacaine in cesarean section (3 arms), sponsored by Shenzhen People's Hospital. Primary endpoint: Incidence of hypotension after anesthesia. Status: unknown.
02
Drugs
bupivacaineropivacaine
03
Conditions
cesarean section
Beyond the preview
Go deeper on NCT03497364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03497364.